Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy

被引:45
作者
Horiguchi, K
Kitagawa-Sakakida, S
Sawa, Y
Li, ZZ
Fukushima, N
Shirakura, R
Matsuda, H
机构
[1] Osaka Univ, Grad Sch Med, Dept Surg, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Organ Transplantat, Suita, Osaka 5650871, Japan
[3] Osaka Univ, Grad Sch Med, Dept Mol Pharmacol, Suita, Osaka 5650871, Japan
关键词
D O I
10.1016/S1053-2498(02)00443-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Chemokine systems probably play a role in transplant vasculopathy; however, a comprehensive study of the expression of chemokines and their receptors in this disease has not been performed. Methods: The expression of all the rat chemokines and chemokine receptor genes for which the nucleotide sequences are known were quantitatively monitored using the fluorescence-based real-time reverse-transcriptase polymerase chain reaction technique, and selected cytokine-receptor pairs were determined using immunohistochemical staining. The analysis covered the whole time course of transplant vasculopathy in 2 different graft models (cardiac and aortic grafts) with 4 different strain combinations of rats. Results: Among the 13 receptor genes examined, the CXCR3, CCR5, and CCR2 genes and those of their corresponding ligands were selectively and strongly induced in grafts that develop transplant vasculopathy. The expression patterns of the receptors were similar in both cardiac and aortic allografts, although their induction and their absolute levels of expression were amplified several fold in the grafted aorta compared with heart grafts. The genes were induced before morphologic changes became apparent and expression was sustained during the whole period of neointimal formation. Interestingly, immunohistochemical staining for CXCR3 showed a unique pattern of expression: we found weak expression on cells in the outer layer of the neointima and adventitia and found the strongest staining in the innermost layer of the neointima. Conclusions:. This study suggested diagnostic as well as potential functional roles of the -chemokine-receptor pairs IP10-CXCR3, RANTES-CCR5, and MCP1-CCR2 in rat models of transplant vasculopathy.
引用
收藏
页码:1090 / 1100
页数:11
相关论文
共 38 条
[11]   Requirement of the chemokine receptor CXCR3 for acute allograft rejection [J].
Hancock, WW ;
Lu, B ;
Gao, W ;
Csizmadia, V ;
Faia, K ;
King, JA ;
Smiley, ST ;
Ling, M ;
Gerard, NP ;
Gerard, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10) :1515-1519
[12]   Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis [J].
Hillebrands, JL ;
van den Hurk, BMH ;
Klatter, FA ;
Popa, ER ;
Nieuwenhuis, P ;
Rozing, J .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (12) :1183-1192
[13]   The Registry of the International Society for Heart and Lung Transplantation: Seventeenth official report - 2000 [J].
Hosenpud, JD ;
Bennett, LE ;
Keck, BM ;
Boucek, MM ;
Novick, RJ .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (10) :909-931
[14]  
ISIK FF, 1992, AM J PATHOL, V141, P1139
[15]   Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2 [J].
Izikson, L ;
Klein, RS ;
Charo, IF ;
Weiner, HL ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1075-1080
[16]   EVIDENCE THAT GRAFT CORONARY ARTERIOSCLEROSIS BEGINS IN THE EARLY PHASE AFTER TRANSPLANTATION AND PROGRESSES WITHOUT CHRONIC IMMUNOREACTION - HISTOPATHOLOGICAL ANALYSIS USING A RETRANSPLANTATION MODEL [J].
IZUTANI, H ;
MIYAGAWA, S ;
SHIRAKURA, R ;
MATSUMIYA, G ;
NAKATA, S ;
SHIMAZAKI, Y ;
MATSUDA, H .
TRANSPLANTATION, 1995, 60 (10) :1073-1079
[17]   Early expression of interferon-γ inducible protein 10 and monokine induced by interferon-γ in cardiac allografts is mediated by CD8+ T cells [J].
Kapoor, A ;
Morita, K ;
Engeman, TM ;
Koga, S ;
Vapnek, EM ;
Hobart, MG ;
Fairchild, RL .
TRANSPLANTATION, 2000, 69 (06) :1147-1155
[18]   Active cell migration in retransplanted rat cardiac allografts during the course of chronic rejection [J].
Kitagawa-Sakakida, S ;
Tori, M ;
Li, ZZ ;
Horiguchi, K ;
Izutani, H ;
Matsuda, H ;
Shirakura, R .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2000, 19 (06) :584-590
[19]   Chronic rejection [J].
Libby, P ;
Pober, JS .
IMMUNITY, 2001, 14 (04) :387-397
[20]   PATHOGENESIS AND PREVENTION OF GRAFT ARTERIOSCLEROSIS IN AN EXPERIMENTAL HEART-TRANSPLANT MODEL [J].
LURIE, KG ;
BILLINGHAM, ME ;
JAMIESON, SW ;
HARRISON, DC ;
REITZ, BA .
TRANSPLANTATION, 1981, 31 (01) :41-47